Europe Neurorehabilitation Devices Market Forecast to 2031 - Regional Analysis - by Product Type, Application, and End User

Description

List of Tables

The Europe neurorehabilitation devices market was valued at US$ 631.51 million in 2023 and is expected to reach US$ 1,509.96 million by 2031; it is estimated to register a CAGR of 11.5% from 2023 to 2031.

Growing Number of Clinical Studies on Neurorehabilitation Devices Drives Europe Neurorehabilitation Devices Market

Clinical studies validate the safety and effectiveness of newly developed neurorehabilitation devices. They provide evidence that neurorehabilitation devices help improve the quality of life of patients suffering from neurological diseases. These studies encourage healthcare centers to integrate these devices into their treatment programs. For instance, "Clinical Study of a Wearable Remote Rehabilitation Training System for Patients With Stroke: Randomized Controlled Pilot Trial" was published in February 2023. The clinical study aimed to design a remote intelligent rehabilitation training system based on wearable devices and human-computer interaction training tasks and evaluate its safety and efficiency.

In December 2022, a clinical trial study, "Effects of robotic rehabilitation using the Erigo device on patients with neurological injury: a systematic review and meta-analysis of randomized clinical trials," was published. The trial studied the effects of the Erigo robotic rehabilitation device on patients with neurological injury based on parameters such as safety, muscle strength, spasticity, functionality, gait/balance, and changes in the level of consciousness. The study concluded that Erigo, as a robotic rehabilitation device, is safe for patients with acquired brain injury and can reduce spasticity in patients with stroke.

Thus, the increasing number of clinical studies on neurorehabilitation devices favors the growth of the market worldwide.

Europe Neurorehabilitation Devices Market Overview

The Ruhr- Universitandaumlt Bochum report revealed that about 270,000 people sustain traumatic brain injuries (TBIs) in Germany annually, and it is highly prevalent among those aged 65 years due to gait imbalance. Therefore, the rising frequency of TBI and other neurological conditions has led to the development of innovative products through strategic approaches. In 2024, Insightec, a pioneer and global leader in focused ultrasound, is pleased to announce that its transcranial MR-guided focused ultrasound (MRgFUS) has been granted NUB status 1 for the treatment of essential tremor (ET) in Germany. This significant milestone is set to improve patient access to cutting-edge, essential tremor treatments within the German healthcare system. Additionally, the major market players and hospitals are involved in the development of innovative products and therapies for neurorehabilitation. For Instance, neurorehabilitation centers in Germany focused on delivering measurable recoveries by using robotics-based treatments. Advanced robotics and other technologies are effective because they engage the brain differently than traditional methods. They intensify effort and provide data to immediately adapt treatment in real time. TRAINM is one such Nero rehab clinic in Germany providing these services. Thus, above mentioned factors are expected to fuel market growth in the coming years.

Europe Neurorehabilitation Devices Market Revenue and Forecast to 2031 (US$ Million)

Europe Neurorehabilitation Devices Market Segmentation

The Europe neurorehabilitation devices market is categorized into product type, application, end user, and country.

By product type, the Europe neurorehabilitation devices market is segmented into neurorobotic system, brain computer interface, non-invasive stimulators, and wearable devices. The brain computer interface segment held the largest share of the Europe neurorehabilitation devices market share in 2023.

In terms of application, the Europe neurorehabilitation devices market is segmented into stroke, traumatic brain injury, spinal cord injury, Parkinson's disease, cerebral palsy, and others. The stroke segment held the largest share of the Europe neurorehabilitation devices market share in 2023.

By end user, the Europe neurorehabilitation devices market is segmented into rehabilitation centers, hospitals & clinics, and home care. The hospitals & clinics segment held the largest share of the Europe neurorehabilitation devices market share in 2023.

Based on country, the Europe neurorehabilitation devices market is segmented into the UK, Germany, France, Spain, Italy, and the Rest of Europe. Germany segment held the largest share of Europe neurorehabilitation devices Market in 2023.

Abbott Laboratories; BIONIK; BioXtreme Ltd; Blackrock Microsystems Inc; Ekso Bionics Holdings Inc; EMOTIV; Hocoma AG; Medtronic Plc; Renishaw Plc; and Tyromotion GmbH are some of the leading companies operating in the Europe neurorehabilitation devices market.

Product Code: BMIRE00031349

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Europe Neurorehabilitation Devices Market Landscape

4.1 Overview
4.2 PEST Analysis
4.3 Average Selling Price

5. Europe Neurorehabilitation Devices Market - Key Market Dynamics

5.1 Europe Neurorehabilitation Devices Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Neurological Diseases
- 5.2.2 Growing Number of Clinical Studies on Neurorehabilitation Devices
5.3 Market Restraints
- 5.3.1 High Costs Associated with Neurorehabilitation Devices
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
- 5.5.1 Technological Advancements
5.6 Impact of Drivers and Restraints:

6. Europe Neurorehabilitation Devices Market - Analysis

6.1 Europe Neurorehabilitation Devices Market Revenue (US$ Million), 2021-2031
6.2 Europe Neurorehabilitation Devices Market Forecast Analysis

7. Europe Neurorehabilitation Devices Market Analysis - by Product Type

7.1 Neurorobotic System
- 7.1.1 Overview
- 7.1.2 Neurorobotic System: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Brain Computer Interface
- 7.2.1 Overview
- 7.2.2 Brain Computer Interface: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Non-invasive Stimulators
- 7.3.1 Overview
- 7.3.2 Non-invasive Stimulators: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Wearable Devices
- 7.4.1 Overview
- 7.4.2 Wearable Devices: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Neurorehabilitation Devices Market Analysis - by Application

8.1 Stroke
- 8.1.1 Overview
- 8.1.2 Stroke: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Traumatic Brain Injury
- 8.2.1 Overview
- 8.2.2 Traumatic Brain Injury: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Spinal Cord Injury
- 8.3.1 Overview
- 8.3.2 Spinal Cord Injury: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Parkinson's Disease
- 8.4.1 Overview
- 8.4.2 Parkinson's Disease: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Cerebral Palsy
- 8.5.1 Overview
- 8.5.2 Cerebral Palsy: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Neurorehabilitation Devices Market Analysis - by End User

9.1 Rehabilitation Centers
- 9.1.1 Overview
- 9.1.2 Rehabilitation Centers: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Hospitals and Clinics: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Home Care
- 9.3.1 Overview
- 9.3.2 Home Care: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Neurorehabilitation Devices Market - Country Analysis

10.1 Europe
- 10.1.1 Europe Neurorehabilitation Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 Europe Neurorehabilitation Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 United Kingdom: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 United Kingdom: Europe Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.2.2 United Kingdom: Europe Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.2.3 United Kingdom: Europe Neurorehabilitation Devices Market Share - by End User
  - 10.1.1.3 Germany: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 Germany: Europe Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.3.2 Germany: Europe Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.3.3 Germany: Europe Neurorehabilitation Devices Market Share - by End User
  - 10.1.1.4 France: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 France: Europe Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.4.2 France: Europe Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.4.3 France: Europe Neurorehabilitation Devices Market Share - by End User
  - 10.1.1.5 Spain: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.5.1 Spain: Europe Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.5.2 Spain: Europe Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.5.3 Spain: Europe Neurorehabilitation Devices Market Share - by End User
  - 10.1.1.6 Italy: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.6.1 Italy: Europe Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.6.2 Italy: Europe Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.6.3 Italy: Europe Neurorehabilitation Devices Market Share - by End User
  - 10.1.1.7 Rest of Europe: Europe Neurorehabilitation Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.7.1 Rest of Europe: Europe Neurorehabilitation Devices Market Share - by Product Type
    - 10.1.1.7.2 Rest of Europe: Europe Neurorehabilitation Devices Market Share - by Application
    - 10.1.1.7.3 Rest of Europe: Europe Neurorehabilitation Devices Market Share - by End User

11. Industry Landscape

11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations

12. Company Profiles

12.1 Blackrock Microsystems Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Hocoma AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Medtronic Plc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Tyromotion GmbH
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Ekso Bionics Holdings Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 BIONIK
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Abbott Laboratories
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Renishaw Plc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 EMOTIV
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 BioXtreme Ltd
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms